Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

The combination of stabilization of fracture-prone lesions, stimulation of bone healing, and anti-tumor effect suggest clinical testing of sicXer and boXer as part of a combined systemic/local treatment strategy in multiple myeloma and non-malignant diseases.

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2024-12-18
DOI
https://doi.org/10.1186/s13045-024-01636-4
Citations
3
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

Eline Menu, Dirk Hose, Thaqif El Khassawna, Marian Kampschulte et al.
3 citations
Journal of Hematology & Oncology
Multiple Myeloma Research and Treatments
1.36
article

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

Eline Menu, Dirk Hose, Thaqif El Khassawna, Marian Kampschulte, Karin Vanderkerken, Jürgen Burhenne, Marcus Rohnke, Anja Seckinger, Susanne Beck, Daniel Zahner, Elke De Bruyne, Francisca Alagboso, Michael Gelinsky, Sabine Wenisch, Reinhard Schnettler, Volker Alt, Ulrich Thormann, Seemun Ray, Christian Heiß, J Bamberger, Kim De Veirman, Anja Henß, Sina Rößler, Thomas Hanke, Anne Hild, Martina Emde-Rajaratnam
article en
3 citations

Abstract

The combination of stabilization of fracture-prone lesions, stimulation of bone healing, and anti-tumor effect suggest clinical testing of sicXer and boXer as part of a combined systemic/local treatment strategy in multiple myeloma and non-malignant diseases.

Journal of Hematology & OncologyVol. 17(1)
Vrije Universiteit Brussel (BE), Justus-Liebig-Universität Gießen (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), University Hospital Regensburg (DE), Max Bergmann Zentrum für Biomaterialien (DE), Technische Universität Dresden (DE)
Deutsche Forschungsgemeinschaft, Universitätsklinikum Regensburg
Good health and well-being
Openalex Percentile: Top 16%
Multiple Myeloma Research and Treatments
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.